JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Total Assets Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual total assets in 2023 was 4.32 Billion CNY , up 10.67% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 4.12 Billion CNY , down -6.68% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual total assets of 3.9 Billion CNY in 2022, up 4.03% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual total assets of 3.75 Billion CNY in 2021, up 1.47% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly total assets of 4.12 Billion CNY for 2024 Q2, down -6.68% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly total assets of 4.12 Billion CNY for 2024 Q3, up 0.1% from previous quarter.

Annual Total Assets Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Total Assets of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Total Assets Total Assets Growth
2023 4.32 Billion CNY 10.67%
2022 3.9 Billion CNY 4.03%
2021 3.75 Billion CNY 1.47%
2020 3.7 Billion CNY -5.52%
2019 3.91 Billion CNY -15.11%
2018 4.61 Billion CNY -0.36%
2017 4.63 Billion CNY -11.55%
2016 5.23 Billion CNY 23.5%
2015 4.24 Billion CNY 5.56%
2014 4.01 Billion CNY 2.25%
2013 3.93 Billion CNY -8.78%
2012 4.3 Billion CNY 14.23%
2011 3.77 Billion CNY 28.07%
2010 2.94 Billion CNY 47.06%
2009 2 Billion CNY -1.48%
2008 2.03 Billion CNY 1.53%
2007 2 Billion CNY -12.82%
2006 2.29 Billion CNY 3.94%
2005 2.2 Billion CNY 15.02%
2004 1.92 Billion CNY 8.8%
2003 1.76 Billion CNY 43.72%
2002 1.22 Billion CNY 11.12%
2001 1.1 Billion CNY 59.04%
2000 695.18 Million CNY 12.78%
1999 616.38 Million CNY 86.37%
1998 330.74 Million CNY 46.04%
1997 226.46 Million CNY 10.97%
1996 204.08 Million CNY 0.0%

Peer Total Assets Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 69.503%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 37.041%
Vcanbio Cell & Gene Engineering Corp., Ltd 5.41 Billion CNY 20.041%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 69.92%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY -46.596%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 82.063%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 72.467%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY -48.158%
Pulike Biological Engineering, Inc. 3.26 Billion CNY -32.636%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY -14.443%
Shanghai Hile Bio-Technology Co., Ltd. 1.65 Billion CNY -161.009%
Qingdao Vland Biotech INC. 3.03 Billion CNY -42.61%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY -36.307%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY -68.06%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY -29.418%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY -41.376%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY 2.877%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY -21.521%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 25.264%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY -21.979%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -168.501%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -171.449%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 24.7%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY -42.75%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 61.854%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY -116.586%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY -49.864%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY -83.647%
Novogene Co., Ltd. 3.59 Billion CNY -20.378%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY -6.202%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -168.316%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY 18.438%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 39.105%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY -10.763%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY -147.736%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY -29.286%
Sinocelltech Group Limited 2.71 Billion CNY -59.162%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY 7.372%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY 1.134%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY -8.983%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 26.803%
Jiangsu gdk Biotechnology Co., Ltd. 1.63 Billion CNY -165.192%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY -76.737%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY -67.736%